Biological Predictors of Treatment Response in Adult Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review
- PMID: 36294881
- PMCID: PMC9605680
- DOI: 10.3390/jpm12101742
Biological Predictors of Treatment Response in Adult Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review
Abstract
Background: Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent condition with onset in childhood and in many cases persisting into adulthood. Even though an increasing number of studies have investigated the efficacy of pharmacotherapy in the management of adult ADHD, few authors have tried to identify the biological predictors of treatment response.
Objectives: To summarize the available data about the biological markers of treatment response in adults affected by ADHD.
Methods: A search on the main biomedical and psychological archives (PubMed, Embase, Scopus, and PsycINFO) was performed. Manuscripts in English, published up to May 2022 and having the biological predictors of treatment response in adults with ADHD as their main topic, were included.
Results: A total of 3855 articles was screened. Twenty-two articles were finally included. Most of the manuscripts studied neuroimaging and electrophysiological factors as potential predictors of treatment response in adult ADHD patients. No reliable markers were identified until now. Promising findings on this topic regard genetic polymorphisms in snap receptor (SNARE) proteins and default mode network-striatum connectivity.
Conclusions: Even though some biological markers seem promising for the prediction of treatment response in adults affected by ADHD, further studies are needed to confirm the available data in the context of precision medicine.
Keywords: adult; attention-deficit/hyperactivity disorder (ADHD); markers; outcome; treatment response.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD).Eur Arch Psychiatry Clin Neurosci. 2014 Nov;264 Suppl 1:S35-43. doi: 10.1007/s00406-014-0542-4. Epub 2014 Sep 18. Eur Arch Psychiatry Clin Neurosci. 2014. PMID: 25231833 Review.
-
Effectiveness of pharmaceutical therapy of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults - health technology assessment.GMS Health Technol Assess. 2010 Sep 7;6:Doc13. doi: 10.3205/hta000091. GMS Health Technol Assess. 2010. PMID: 21289886 Free PMC article.
-
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.Cochrane Database Syst Rev. 2018 Aug 9;8(8):CD007813. doi: 10.1002/14651858.CD007813.pub3. Cochrane Database Syst Rev. 2018. PMID: 30091808 Free PMC article.
-
Attention-deficit/ hyperactivity disorder mobile apps: A systematic review.Int J Med Inform. 2020 Jun;138:104133. doi: 10.1016/j.ijmedinf.2020.104133. Epub 2020 Apr 2. Int J Med Inform. 2020. PMID: 32283479
-
Attention network hypoconnectivity with default and affective network hyperconnectivity in adults diagnosed with attention-deficit/hyperactivity disorder in childhood.JAMA Psychiatry. 2013 Dec;70(12):1329-37. doi: 10.1001/jamapsychiatry.2013.2174. JAMA Psychiatry. 2013. PMID: 24132732
Cited by
-
Attention-deficit/hyperactivity disorder (ADHD) in adults: a multilayered approach to a serious disorder of inattention to the future.Arq Neuropsiquiatr. 2024 Jul;82(7):1-12. doi: 10.1055/s-0044-1791513. Epub 2024 Oct 2. Arq Neuropsiquiatr. 2024. PMID: 39357854 Free PMC article. Review.
References
-
- Fayyad J., Sampson N.A., Hwang I., Adamowski T., Aguilar-Gaxiola S., Al-Hamzawi A., Andrade L.H., Borges G., de Girolamo G., Florescu S., et al. The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys. Atten. Defic. Hyperact. Disord. 2017;9:47–65. doi: 10.1007/s12402-016-0208-3. - DOI - PMC - PubMed
-
- Sibley M.H., Arnold L.E., Swanson J.M., Hechtman L.T., Kennedy T.M., Owens E., Molina B.S.G., Jensen P.S., Hinshaw S.P., Royet A., et al. Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD. Am. J. Psychiatry. 2022;179:142–151. doi: 10.1176/appi.ajp.2021.21010032. - DOI - PMC - PubMed
-
- Capuzzi E., Capellazzi M., Caldiroli A., Cova F., Auxilia A.M., Rubelli P., Tagliabue I., Zanvit F.G., Peschi G., Buoli M., et al. Screening for ADHD Symptoms among Criminal Offenders: Exploring the Association with Clinical Features. Healthcare. 2022;10:180. doi: 10.3390/healthcare10020180. - DOI - PMC - PubMed